Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination (FDC) of BEM, a nucleotide analog ...

RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...

A presentation outlining the project was made at the divisional commissionerate on Wednesday. Divisional Commissioner ...

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease ...

The Ghana Shippers’ Authority (GSA) has held a high-level Exporters’ Forum aimed at strengthening collaboration among ...

Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...

A massive influx of applicants has filed to take advantage of Minnesota’s new paid leave program open to “undocumented ...

Indonesia's free nutritious meal project (MBG), has been running for over a year. Several problems continue to haunt the free ...

Do No Harm alleges Utah Department of Health and Human Services "systematic review" misleads on transgender outcomes.

The Ghana Shippers’ Authority (GSA) has held a high-level exporters’ forum aimed at strengthening collaboration among ...